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BACKGROUND: Nasopharyngeal carcinoma (NPC) is malignant tumor growing in nasopharynx with a predilection in fossa Rossenmuller and 
nasopharyngeal roof. This research aimed to prove 
whether the means of argyrophilic nucleolar organizer 
region (mAgNOR) can predict the success of treatment in 
nasopharyngeal carcinoma patients. 
METHODS: We used diagnostic test method with 
longitudinal design and purposive sampling technique. 
Endoscopic biopsy examination was performed on 15 
nasopharyngeal carcinoma patients before and after 
therapy, 13 patients underwent chemotherapy and other two 
underwent chemoradiotherapy. Tumor tissues were stained 
and AgNOR was calculated.
RESULTS: Based on the tumor stage, sample characteristic 
showed 3 patients (20%) were in stage II, 3 patients (20%) 
in stage III, and 9 patients (60%) in stage IV, with pre- and 
post-therapy mAgNOR were 1.610±0.988 and 1.000±0.000, 
Abstract respectively in stage II, 1.100±0.092 and 1.000±0.000, respectively in stage III, 1.226±0.265 and 1.107±0.164, 
respectively in stage IV patients. Based on histopathology 
type, 4 patients (26.7%) had non keratinizing squamous 
cell carcinoma with pre- and post-therapy mAgNOR 
were 1.117±0.134 and 1.060±0.120, respectively, while 
11 patients (73.3%) had undifferentiated squamous cell 
carcinoma with pre- and post-therapy mAgNOR were 
1.335±0.528 and 1.065±0.146, respectively. Overall the 
pre-therapy were significantly higher than post-therapy 
mAgNOR. In subgroups there are significant differences in 
stage IV and type 3. 
CONCLUSION: The values of AgNOR were decreased in 
all NPC stages and significantly decreased in undifferentiated 
squamous cell carcinoma. AgNOR can be used to predict 
the successfulness of therapy in NPC.
KEYWORDS: nasopharyngeal carcinoma, therapy, 
proliferation, mAgNOR
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Introduction
Nasopharyngeal carcinoma (NPC) is a nonlymphomatous 
squamous cell carcinoma that occurs in the epithelial lining 
of the nasopharynx. This neoplasm shows varying degrees 
of differentiation and is frequently seen in pharyngeal recess 
(Rossenmuller’s fossa), posteromedial to the medial crura 
of the Eustachian tube opening in the nasopharynx.(1,2)
 Epidemiologically of NPC indicated, the highest rate 
was found in the Province of South China which are 40-50 
cases among 100,000 residents. In Indonesia, NPC ranks 
4th after cancer of uterus, breast and skin, with an incidence 
of 4.7 per 100,000 population. In Makassar, South Sulawesi 
Province, Kuhuwael reported in Dadi Hospital and Dr. 
Wahidin Sudirohusodo General Hospital over a period of 
10 years (1990-1999), there were 274 (47.98%) cases of the 
malignant tumors over head and neck with a comparison 
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Methods
between men and women was 2.6:1. Bastiana reported 
in Dr.Wahidin Sudirohusodo General Hospital within 
the period of 10 years (2000-2009), there were 362 cases 
(57.28%) of the malignant tumors over head and neck.(3,4)
 Radiotherapy has been the primary treatment for NPC 
for years. This is because the nasopharynx adjacent to critical 
structures and properties of NPC infiltration, resulting 
in surgery of the primary tumor has been difficult. NPC 
is generally inoperable, more responsive to radiotherapy 
and chemotherapy  than  other  head  and neck malignant 
tumors.(5,6)
 Management of an advanced NPC stage is 
chemotherapy combined with radiotherapy. Chemotherapy 
is usually used in cases of recurrent or metastatic NPCs. 
The working mechanism functions as an anti-metabolite 
chemotherapy, disrupting the structure and function of DNA 
and as mitotic inhibitor. Antimetabolites act by inhibiting 
the biosynthesis of purine or pyrimidine, thus changing the 
structure of DNA and holding cell replication.(7)
 Cell proliferation can be studied by destroying tissues 
such as "flowcytometry” method or by maintaining the tissues 
such as labeling with a radioisotope, Ki-67, proliferating cell 
nuclear antigen (PCNA) and staining argyrophilic nucleolar 
organizer region (AgNOR) techniques. The advantage to 
study cell proliferation without destroying the tissues is the 
relationship between subpopulations of cells in the tumor 
tissues is retained.(8)
 AgNOR is a proliferation assessment by calculating 
the "nucleolar organizer regions" (NOR) which is the curve 
ribosomal DNA (rDNA) transcribed into ribosomal RNA 
(rRNA) by polymerase assistance. NOR is located in the 
short arm of acrocentric chromosome (number 13, 14, 15, 
21 and 22) in human and ultra-structurally seen to associate 
with fibrils in the phase of interphase. NOR contains genes 
of 18s and 28s rRNAs in shape, which is essential for protein 
synthesis.(8,9) Neoplastic changes at the nucleus that is the 
size of enlarged, irregular shape, marginality to the peripheral 
location of the nucleus. Neoplastic cell transformation 
characterized by an increase in protein synthesis. Thus the 
increase in the number of proteins associated with NORs 
describe the increase in the transcription of rRNA. These 
figures reflect an increase in cell proliferation activity. 
AgNOR staining technique is a technique in which the 
silver colloidal silver staining will bind to form a compound 
NOR-associated proteins (NORAP) and AgNOR (silver 
deposition). By AgNOR specks of light microscopy based 
on the nature argilliferous visualized form of grains of black 
in the nucleus.(10,11)
  The relationship between radiosensitivity and cell 
proliferation is complex and the pattern depends on the 
phase and the cell cycle, mitosis frequency and the period 
of interphase. High frequency mitotic cells (short interphase 
phase) has a shorter recovery period prior the next mitosis 
phase after radiation exposure. Likewise high proliferating 
tumor cells are generally more radiosensitive than those 
with low proliferation rate, as they are more susceptible 
to die due to radiation effects. Other factors that influence 
the pattern are histological event, growth fractions and 
spontaneous dead tumor cells.(9)  
 Heber, et al., reported that mean differences between 
the AgNOR of pre-radiotherapy and after the first fraction 
of radiotherapy showed a positive correlation, healing the 
cancer within one year post-radiotherapy. A similar result 
was reported by Irawan showing that there were differences 
between proliferative activity (counted AgNOR) of pre- and 
post-therapy in patients with advanced stage carcinoma of 
cervix uteri in which the proliferative activity of pre-therapy 
is higher than those post-therapy.(12,13)
The method used in this experiment was diagnostic test 
with longitudinal design. The research was conducted in 
Otolaryngology and Anatomy Pathology Department of 
Dr. Wahidin Sudirohusodo General Hospital in cooperation 
with the Anatomy Pathology Department of Cipto 
Mangunkusumo General Hospital Jakarta, from November 
2014 to May 2015 who signed the post-informed consent 
form to participate. Approval was released by the ethics 
committee of human protection in biomedical research, 
Medical Faculty of Hasanuddin University number 02271/
H4.8.4.5.31/PP36-KOMETIK/2014. 
 Sampling was conducted by purposive sampling 
technique. Inclusion criteria were patients with NPC based 
on the results of histopathological examination included in 
the study that were willing to sign statement to participate in 
the study after receiving an explanation (informed consent). 
Exclusion criteria were patients with another primary tumor. 
The examination of endoscopic biopsy was performed on 
15 nasopharynx carcinoma patients before and after therapy, 
13 samples underwent chemotherapy and the other 2 
samples underwent chemoradiotherapy.  The silver-staining 
of NORs was applied to 30 paraffin sections of NPC biopsy 
specimen.
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AgNORs Staining Procedure
Histological sections were stained with haematoxylin and 
eosin. Also, AgNORs by method of Crocker, et al., by taking 
4μ thick sections were made for each case, deparaffinize in 
Xylol, hydrate through graded alcohol to water, incubate 
the sections in freshly prepared working solution i.e., silver 
colloid developer (containing one part by volume of 2% 
gelatin in 1% formic acid and two parts by volume of 50% 
aqueous silver nitrate solution) in a closed coplin jar for 
30 to 45 minutes in dark room at room temperature. This 
silver colloidal solution was washed with three changes of 
deionized water for 2 minutes each and blot the section, and 
dehydrate through ascending grade of alcohol cleared in 
xylene mounted.(14)
AgNORs Count
For counting, most cellular representative areas were 
elected. In each case approx 100 nuclei were examined under 
X 100 oil immersion lens. Multiple regions were examined 
in each section by selecting microscopic fields at random 
and by taking 100 cells into account, the means of AgNOR 
(mAgNOR) per cell is then calculated simultaneously. We 
also observe the morphology of NOR dots to avoid biased 
results. The counts were done by two different observers. 
AgNORs dots are intranuclear black to brownish black 
against pale yellow to golden yellow nuclear background.
Statistical Analysis
The statistical analysis was done using Wilcoxon test and 
the statistical significance was set at p<0.05.
Results
Table 1. Distribution of the samples by age, gender, NPC stage 
and histopathology type.
We performed this study on 15 NPC patients, 13 of them 
had underwent chemotherapy and the other 2 patients had 
underwent chemoradiotherapy.  General distribution of the 
subjects is shown in Table 1.
 Table 2 shows mAgNOR pre- and post-therapy in 
NPC patients. There is significant difference between the 
mAgNOR pre- and post-therapy based on statistical test 
(p=0.002).
 Table 3 shows the mAgNOR pre- and post-therapy 
in NPC patients based on the stage of tumor. There is a 
significant difference between the means in stage IV with 
p=0.018, but no significant difference between the means in 
stage II and III. 
 Table 4 shows the mAgNOR pre- and post-therapy 
in NPC patients based on the histopathology type. The 
n %
Age 
31-40 years 5 33.3
41-50 years 4 26.7
51-60 years 5 33.3
≥60 years 1 6.7
Gender 
Men 14 93.3
Women 1 6.7
NPC stage
Stage II 3 20.0
Stage III 3 20.0
Stage IV 9 60.0
Histopathology type
WHO  type 1 4 26.7
WHO  type 2 11 73.3
Variable
Subjects (n=15)
Discussion
In this study, the distribution of samples by gender were 
14 (93.3%) females and 1 (6.7%) male. The ratio between 
female and male patients is in contrast with the literature 
which is 2.6:1 in ratio, caused by the analyzed samples are 
only those that meets the selection criterias, not all patients 
who came in that mean time.(15)
 Based on the age, the subjects was included into two 
groups: 31-40 years old (33%) and 51-60 years old (33%). 
The youngest is 35 years and the oldest is 65 years. 
 There are three factors influencing occurrence of the 
malignancies which are individual, environment, and agents. 
Epstein Barr virus is an agent associated with the occurrence 
of nasopharyngeal carcinoma, therefore the infection may 
occur at youngs.  Ebstein Barr virus infection, led to the 
transformation of individual DNA, whose expression is 
influenced by other factors, i.e., environment and host, so 
that nasopharyngeal carcinoma is also found in the aged. 
difference between the means in the WHO type 3 was 
significant  with p=0.008, but no significant difference in 
WHO type 2 with p=0.102.
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Table 3. mAgNOR pre- and post-therapy in NPC patients based on the  stage of tumor.
Table 4. The mAgNOR pre- and post- therapy in NPC patients based on  histopathology type.
Table 2. The mAgNOR pre- and post-therapy in NPC patients.
mAgNOR of 
NPC patient n
Median
(Min-Max) Mean±SD p
Pre-therapy 15 1.00-2.75 1.277±0.461
Post-therapy 15 1.00-1.48 1.064±0.136
0.002
Stage mAgNORvalue n Min-Max Mean±SD p
Pre-therapy 3 1.00-2.75 1.610±0.988
Post-therapy 3 1.00-1.00 1.000±0.000
Pre-therapy 3 1.02-1.20 1.100±0.092
Post-therapy 3 1.00-1.00 1.000±0.000
Pre-therapy 9 1.00-1.66 1.226±0.265
Post-therapy 9 1.00-1.48 1.107±0.164
0.18
0.109
0.018*
Stage II
Stage III
Stage IV
Histopathology
Type
mAgNOR
value n Min-Max Mean±SD p
Pre-therapy 4 1.00-1.31 1.117±0.134
Post-therapy 4 1.00-1.24 1.060±0.120
Pre-therapy 11 1.00-2.75 1.335±0.528
Post-therapy 11 1.00-1.48 1.065±0.146
WHO Type 2
WHO Type 3
0.102
0.008*
 Mostly, the NPC patients were in the IV stage, which 
are 9 or 60%, similar with the previous research conducted 
at Dr. Wahidin Sudirohusodo General Hospital.(16) Another 
previous study conducted by Jeane and Kuhuwael in Dr. 
Wahidin Sudirohusodo General Hospital also found the 
same,  where the majority of NPC patients was stage IV 
(56%).(17)
 Based on the histopathology type, the majority found 
was undifferentiated carcinoma cells squamous (WHO type 
3) which is 73.3%. It is similar with the findings by Jeane 
and Kuhuwael reported that WHO type 3 was the highest 
about 70%, Savitri found 80.9% of the same type.(17,18) 
Based on the literature the distribution of histopathology in 
South China is WHO type 1 (2%), WHO type 2 (3%) and 
the WHO type 3 (95%). While in North America, WHO type 
1 (25%), WHO type 2 (12%) and the WHO type 3 (63%). 
The WHO  type  3  is  frequently  found  in  endemic areas 
of NPC.(19)
 This study showed that mAgNOR pre-therapy 
generally higher than post-therapy. There are decreases in 
the mAgNOR after treatment of the patients, and proven 
to be statistically significant. The high mAgNOR pre- 
therapy marks an increase in activity of the malignant 
cells proliferation. This is similar to the previous study in 
Malaysia Mohan and Hayati, reported that the mAgNOR 
past-therapy was lower, as respons on the radiation to the 
head and neck squamous cell carcinoma. Research at Dr. 
Kariadi Hospital performed by Irawan regarding cervical 
cancer had the same result. But there is no research 
that shows the mAgNOR pre- and post-therapy in NPC 
patients. In counting AgNOR, the higher the mean value 
the higher proliferation of cancer cells that would be more 
radiosensitive to radiation compared with cancer cells at 
lower proliferation rate. The higher proliferation of cells the 
longer encountered S phase (DNA synthesis phase) which 
is mostly sensitive to radiation. Kinoshita stated AgNOR 
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The values of AgNOR were decrease in the all NPC stages 
and significantly decrease in undifferentiated squamous cell 
carcinoma (WHO type 3). AgNOR could be used to predict 
the successfulness of therapy in NPC.
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Conclusion
number reflects the activity of cancer cells and numbers of 
researchers  agree  that  the  proliferation of cancer cells 
is very   sensitive  to   radiation   and   other   anti  cancer 
drugs.(13,20,21)
 In malignancies including in nasopharyngeal 
carcinoma there are uncontrolled cell division, resulting 
in high activity of the cells to proliferate. After therapy 
however, the proliferation activity will decrease as a sign 
of successful therapy, that can be examined by counting 
AgNOR.(22)
 The decreased of mAgNOR post-therapy in the 
presenting study happened in all stages (II, III and IV). 
This proves a decrease in cell proliferation activity which 
indicates the response of tumor cells to the treatment. A 
slight decrease of AgNOR in stage II which is not significant 
statistically, is caused by too little samples at this stage.
 Several studies on various types of carcinomas 
(ovarian,  cervix, bone, etc.)  also  showed  the  same effects. 
But  less studies finding a significant  relationship  between 
the    decrease    in   the  mAgNOR   post-therapy   with 
stage.(13,23,24)
 Chemoradiotherapy is a chemotherapy combined with 
radiotherapy concurrently used to control tumor lokoregional 
and improve the survival of patients in order to overcome 
cancer cells systemically through microcirculation. In 
this study most of the samples will undergo neoadjuvant 
chemotherapy intended to reduce the size of the tumor 
before radiotherapy. Neoadjuvant chemotherapy was 
based on considerations that the tumor vascular bed is 
still in intact, therefore the penetration of the drug through 
the tumor mass is still adapted. In addition, treated early 
chemotherapy could eradicate systemic micrometastases as 
early as possible. Neoadjuvant chemotherapy over head and 
neck of stage II-IV malignancies were reported with overall 
response rates reached 80%-90% and  complete response 
approximately reached 50%. Neoadjuvant chemotherapy 
treated prior to definitive radiation therapy could retain the 
function of the preserving organ.(25,26)
 The level of differentiation is generally associated 
with malignancy and proliferation rate of cells, thus 
undifferentiated cells type (typical in WHO type 3) have 
higher proliferation rate, reflected in higher AgNOR value. 
As found in this study that the mean AgNOR pre- and post-
therapy for the WHO type 3 were statistically different in 
significant level, therefore, in accordance to the research 
conducted in 70 patients with NPC paraffin specimens, 
findings the mean AgNOR for WHO type 3 was higher than 
those in WHO type 2, our result is proven to be reliably 
supported.(27)
 The weakness of this research is limited of time, so that 
only a few samples can be observed until chemoradiotherapy 
completion.
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